Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs
Go back to Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs| Actinium Pharmaceuticals, Inc. (NYSE: ATNM) | Delayed: 1.33 +0.02 (1.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.31 | 52 Week High | $3.50 | |||
| Open | $1.31 | 52 Week Low | $0.86 | |||
| Day High | $1.38 | P/E | N/A | |||
| Day Low | $1.29 | EPS | $-7.61 | |||
| Volume | 85,496 | |||||
